Anzeige
❌
Mehr »
Montag, 16.11.2026 - Börsentäglich über 12.000 News
Pelican AI: +34,75% in Frankfurt! Ist das erst der Anfang einer großen Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
QB

WKN: A2P8F1 | ISIN: CA74764Y2050 | Ticker: 0K91
Stuttgart
16.11.26 | 07:34
1,335 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
QUANTUM BIOPHARMA LTD Chart 1 Jahr
5-Tage-Chart
QUANTUM BIOPHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,3351,56807:49

Aktuelle News zur QUANTUM BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
QUANTUM BIOPHARMA Aktie jetzt für 0€ handeln
FrQuantum BioPharma Non-GAAP EPS of -$0.061
FrQuantum BioPharma reports Q3 cash position, Lucid-MS trial update3
FrQuantum BioPharma achieve 91% increase in Shareholder Equity and Liquidity in Q3 2026 as Lucid-MS Phase 2 Trial Advances into Study Start-Up3
DoQuantum Biopharma Ltd. - 6-K, Report of foreign issuer1
MiQuantum Biopharma Ltd: Quantum Biopharma shareholders approve AGM resolutions10
MiQuantum BioPharma Announces Results of Annual General and Special Meeting of Shareholders and Closing of Private Placement of Class A Multiple Voting Shares7
05.11.Quantum BioPharma legt Nachtrag zur Abstimmung über Aktienzusammenlegung vor7
05.11.Quantum BioPharma files supplement on share consolidation vote4
05.11.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer3
14.10.Quantum BioPharma's Phase 2 Shows Where Biotech Value Actually Gets Built12
12.10.Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial3
08.10.World Renowned Law Firm Grant & Eisenhofer Appointed Lead Counsel In Newly Consolidated Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares7
06.10.Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis848TORONTO, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company focused on developing innovative therapies and technologies...
► Artikel lesen
06.10.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer2
06.10.EXCLUSIVE: Thermo Fisher To Support Quantum Biopharma in Progressive Multiple Sclerosis Drug Trial6
25.09.Quantum BioPharma Advances Lucid-MS Toward Phase 2 Trial Following FDA IND Clearance7
17.09.Quantum BioPharma reports Q4 results28
17.09.Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target470TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of...
► Artikel lesen
15.09.ArcStone US Corp.: Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto310Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building...
► Artikel lesen
15.09.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer4
1 2 3 Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3